Electronic Resource
[s.l.]
:
Nature Publishing Group
Nature biotechnology
23 (2005), S. 1147-1157
ISSN:
1546-1696
Source:
Nature Archives 1869 - 2009
Topics:
Biology
,
Process Engineering, Biotechnology, Nutrition Technology
Notes:
[Auszug] The most significant recent advances in the application of monoclonal antibodies (mAbs) to oncology have been the introduction and approval of bevacizumab (Avastin), an anti–vascular endothelial growth factor antibody, and of cetuximab (Erbitux), an anti–epidermal growth factor ...
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1038/nbt1137
Permalink
|
Location |
Call Number |
Expected |
Availability |